Jazzar U, et al. - Researchers used the Surveillance, Epidemiology, and End Results-Medicare database to determine the prevalence and types of psychiatric illnesses diagnosed after muscle-invasive bladder cancer treatment and to determine their impact on survival outcomes in patients who were diagnosed with clinical stage T2 through T4a bladder cancer from January 1, 2002 to December 31, 2011. A psychiatric disorder was diagnosed in one-half of patients with muscle-invasive bladder cancer who underwent treatment, with those undergoing radical cystectomy having a significantly greater risk of having one compared with those who received radiotherapy and/or chemotherapy. The development of a psychiatric disorder in these patients led to worse survival outcomes vs those who did not have a posttreatment psychiatric diagnosis.